Therapy for Hepatitis C Virus (HCV) in Primary Treatment Failure in Pakistan
Condition(s):Hepatitis CLast Updated:September 7, 2023Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Hepatitis CLast Updated:September 7, 2023Enrolling by invitation
Condition(s):Lung Cancer; Lung Cancer Stage I; Lung Cancer Stage IILast Updated:September 11, 2023Recruiting
Condition(s):Non-Alcoholic Fatty Liver Disease; Non-Alcoholic Fatty Liver; Non-Alcoholic SteatohepatitisLast Updated:May 25, 2023Completed
Condition(s):Immune Tolerance; Immunosuppression; Liver Transplant; ComplicationsLast Updated:November 27, 2023Not yet recruiting
Condition(s):Nonalcoholic Fatty Liver Disease; DyslipidemiasLast Updated:July 9, 2021Completed
Condition(s):Renal Transplant; Renin-Angiotensin System; Rejection Acute Renal; Rejection Chronic Renal; Rejection of Renal TransplantLast Updated:November 8, 2017Completed
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:December 1, 2023Enrolling by invitation
Condition(s):Radiotherapy Side EffectLast Updated:March 20, 2023Recruiting
Condition(s):Atrial FibrillationLast Updated:November 8, 2016Unknown status
Condition(s):Primary Sclerosing CholangitisLast Updated:January 9, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.